Advertisement
+ News Categories + Corporate Categories + Report Categories

NEXT ARTICLE

ImmunGene Receives $244,479 Grant Under the Patient Protection and Affordable Care Program for Its Anti-Cancer Technology

00:30 EST 22 Nov 2010 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
THOUSAND OAKS, Calif., Nov 22, 2010 /PRNewswire/ -- ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics with numerous anti-cancer functions built into a single therapy, announced today that it has received a...

Other Sources for this Article